226 related articles for article (PubMed ID: 35179705)
1. Cannabinoid-Related Acute Pancreatitis: An Update from International Literature and Individual Case Safety Reports.
Azam C; Buscail L; Culetto A; Lapeyre-Mestre M
Drug Saf; 2022 Mar; 45(3):215-235. PubMed ID: 35179705
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Rice J; Cameron M
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
[TBL] [Abstract][Full Text] [Related]
3. Place of therapeutic cannabis in France and safety data: A literature review.
Corso B; Bacle A; Demay E; Mercerolle M; Pelletier R; Gicquel T; Le Daré B
Ann Pharm Fr; 2023 Jun; 81(4):583-595. PubMed ID: 36841395
[TBL] [Abstract][Full Text] [Related]
4. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
6. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
7. Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.
Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
Psychopharmacology (Berl); 2022 May; 239(5):1211-1230. PubMed ID: 34613429
[TBL] [Abstract][Full Text] [Related]
8. Strokes are possible complications of cannabinoids use.
Wolff V; Jouanjus E
Epilepsy Behav; 2017 May; 70(Pt B):355-363. PubMed ID: 28237318
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
Michalski CW; Laukert T; Sauliunaite D; Pacher P; Bergmann F; Agarwal N; Su Y; Giese T; Giese NA; Bátkai S; Friess H; Kuner R
Gastroenterology; 2007 May; 132(5):1968-78. PubMed ID: 17484889
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
11. Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines - Identification of potential distinguishing markers.
Scheunemann A; Elsner K; Germerott T; Hess C; Zörntlein S; Röhrich J
Forensic Sci Int; 2021 May; 322():110773. PubMed ID: 33839545
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of escalating cannabinoid doses in healthy cats.
Kulpa JE; Paulionis LJ; Eglit GM; Vaughn DM
J Feline Med Surg; 2021 Dec; 23(12):1162-1175. PubMed ID: 33769105
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic, Ethnocultural, Substance- and Cannabinoid-Related Epidemiology of Down Syndrome USA 1986-2016: Combined Geotemporospatial and Causal Inference Investigation.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293924
[TBL] [Abstract][Full Text] [Related]
14. Nabilone Impairs Spatial and Verbal Working Memory in Healthy Volunteers.
Kassim FM; Tod S; Rodger J; Hood SD; Lee JWY; Albrecht MA; Martin-Iverson MT
Cannabis Cannabinoid Res; 2024 Feb; 9(1):199-211. PubMed ID: 36201240
[No Abstract] [Full Text] [Related]
15. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Spanagel R; Bilbao A
Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
18. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].
Morgan CJ; Schafer G; Freeman TP; Curran HV
Br J Psychiatry; 2010 Oct; 197(4):285-90. PubMed ID: 20884951
[TBL] [Abstract][Full Text] [Related]
19. Cannabis: Chemistry, extraction and therapeutic applications.
Pattnaik F; Nanda S; Mohanty S; Dalai AK; Kumar V; Ponnusamy SK; Naik S
Chemosphere; 2022 Feb; 289():133012. PubMed ID: 34838836
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
